SEARCH

SEARCH BY CITATION

References

  • Ambrosino, C. & Nebreda, A.R. (2001) Cell cycle regulation by p38 MAP kinase. Biology of the Cell, 93, 4751.
  • Bulavin, D.V. & Fornace, Jr, A.J. (2004) p38 MAP kinase’s emerging role as a tumor suppressor. Advances in Cancer Research, 92, 95118.
  • Bulavin, D.V., Demidov, O.N., Saito, S., Kauraniemi, P., Phillips, C., Amundson, S.A., Ambrosino, C., Sauter, G., Nebreda, A.R., Anderson, C.W., Kallioniemi, A., Fornace, Jr, A.J. & Appella, E. (2002) Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nature Genetics, 31, 210215.
  • Bulavin, D.V., Phillips, C., Nannenga, B., Timofeev, O., Donehower, L.A., Anderson, C.W., Appella, E. & Fornace, Jr, A.J. (2004) Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16Ink4a–p19Arf pathway. Nature Genetics, 36, 343350.
  • Cai, B. & Xia, Z. (2008) p38 MAP kinase mediates arsenite-induced apoptosis through FOXO3a activation and induction of Bim transcription. Apoptosis, 13, 803810.
  • Chao, J.I., Kuo, P.C. & Hsu, T.S. (2004) Down-regulation of surviving in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells. The Journal of Biological Chemistry, 279, 2026720276.
  • Cheng, Y., Chang, L.W. & Tsou, T.C. (2006) Mitogen-activated protein kinases mediate arsenic-induced down-regulation of survivin in human lung adenocarcinoma cells. Archives of Toxicology, 80, 310318.
  • Deacon, K., Mistry, P., Chernoff, J., Blank, J.L. & Patel, R. (2003) p38 mitogen-activated protein kinase mediates cell death and p21-activated kinase mediates cell survival during chemotherapeutic drug-induced mitotic arrest. Molecular Biology of the Cell, 14, 20712087.
  • Dighiero, G. & Hamblin, T.J. (2008) Chronic lymphocytic leukaemia. Lancet, 317, 10171029.
  • Dolado, I., Swat, A., Ajenjo, N., De Vita, G., Cuadrado, A. & Nebreda, A.R. (2007) p38α MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell, 11, 191205.
  • de Graaf, A.O., van Krieken, J.H., Tonnissen, E., Wissink, W., van de Locht, L., Overes, I., Dolstra, H., de Witte, T., van der Reijden, B.A. & Jansen, J.H. (2005) Expression of C-IAP1, C-IAP2 and SURVIVIN discriminates different types of lymphoid malignancies. British Journal of Haematology, 130, 852859.
  • Hallahan, A.R., Pritchard, J.I., Chandraratna, R.A., Ellenbogen, R.G., Gever, J.R., Overland, R.P., Strand, A.D., Tapscott, S.J. & Olson, J.M. (2003) BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nature Medicine, 9, 10331038.
  • Han, J. & Sun, P. (2007) The pathways to tumor suppression via route p38. Trends in Biochemical Sciences, 32, 364371.
  • Hui, D., Satkunam, N., Al Kaptan, M., Reiman, T. & Lai, R. (2006) Pathway-specific apoptotic gene expression profiling in chronic lymphocytic leukemia and follicular lymphoma. Modern Pathology, 19, 11921202.
  • Hui, L., Bakiri, L., Mairhorfer, A., Schweifer, N., Haslinger, C., Kenner, L., Komnenovic, V., Scheuch, H., Beug, H. & Wagner, E.F. (2007a) p38α suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nature Genetics, 39, 741749.
  • Hui, L., Bakiri, L., Stepniak, E. & Wagner, E.F. (2007b) p38α: a suppressor of cell proliferation and tumorigenesis. Cell Cycle, 6, 24292433.
  • Hung, J.H., Lu, Y.S., Wang, Y.C., Ma, Y.H., Wang, D.S., Kulp, S.K., Muthusamy, N., Byrd, J.C., Cheng, A.L. & Chen, C.S. (2008) FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase Cδ signaling. Cancer Research, 68, 12041212.
  • Juretic, N., Santibanez, J.F., Hurtado, C. & Martinez, J. (2001) ERK1,2 and p38 pathways are involved in the proliferative stimuli mediated by urokinase in osteoblastic SaOS-2 cell line. Journal of Cellular Biochemistry, 83, 9298.
  • Kennedy, N.J., Cellurale, C. & Davis, R.J. (2007) A radical role for p38 MAPK in tumor initiation. Cancer Cell, 11, 101103.
  • Lavoie, J.N., L’Allemain, G., Brunet, A., Muller, R. & Pouyssegur, J. (1996) Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. The Journal of Biological Chemistry, 271, 2060820616.
  • Li, F., Ling, X., Huang, H., Brattain, L., Apontes, P., Wu, J., Binderup, L. & Brattain, M.G. (2005) Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines. Oncogene, 24, 13851395.
  • Liu, Q., Zhao, X., Frissora, F., Ma, Y., Santhanam, R., Jarjoura, D., Lehman, A., Perrotti, D., Chen, C.S., Dalton, J.T., Muthusamy, N. & Byrd, J.C. (2008) FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma. Blood, 111, 275284.
  • Losa, J.H., Parada Cobo, C., Viniegra, J.G., Sanchez-Arevalo Lobo, V.J., Ramon y Cajal, S. & Sanchez-Prieto, R. (2003) Role of the p38 MAPK pathway in cisplatin-based therapy. Oncogene, 22, 39984006.
  • Manke, I.A., Nguyen, A., Lim, D., Stewart, M.Q., Elia, A.E.H. & Yaffe, M.B. (2005) MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Molecular Cell, 17, 3748.
  • Matsuda, S., Minowa, A., Suzuki, S. & Koyasu, S. (1999) Differential activation of c-Jun NH2-terminal kinase and p38 pathways during FTY720-induced apoptosis of T lymphocytes that is suppressed by the extracellular signal-regulated kinase pathway. The Journal of Immunology, 162, 33213326.
  • Montserrat, E. & Moreno, C. (2008) Chronic lymphocytic leukaemia: a short overview. Annals of Oncology, 19(Suppl. 7), vii320vii325.
  • Nebreda, A.R. & Porras, A. (2000) p38 MAP kinases: beyond the stress response. Trends in Biochemical Sciences, 25, 257260.
  • Olson, J.M. & Hallahan, A.R. (2004) p38 MAP kinase: a convergence point in cancer therapy. Trends in Molecular Medicine, 10, 125129.
  • Ono, K. & Han, J. (2000) The p38 signal transduction pathway: activation and function. Cellular Signalling, 12, 113.
  • Park, J.M., Greten, F.R., Li, Z.W. & Karin, M. (2002) Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science, 297, 20482051.
  • Pedersen, I.M., Buhl, A.M., Klausen, P., Geisler, C.H. & Jurlander, J. (2002) The chimeric anti-CD20 antibody rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 mitogen activated protein-kinase-dependent mechanism. Blood, 99, 13141319.
  • Pepper, C., Thomas, A., Hoy, T., Milligan, D., Bentley, P. & Fegan, C. (2003a) The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro. Blood, 101, 24542460.
  • Pepper, C., Thomas, A., Fegan, C., Hoy, T. & Bentley, P. (2003b) Flavopiridol induces apoptosis in B-cell chronic lymphocytic leukaemia cells through a p38 and ERK MAP kinase-dependent mechanism. Leukemia and Lymphoma, 44, 337342.
  • Puri, P.L., Wu, Z., Zhang, P., Wood, L.D., Bhakta, K.S., Han, J., Feramisco, J.R., Karin, M. & Wang, J.Y. (2000) Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes & Development, 14, 574584.
  • Seo, S.K., Lee, H.C., Woo, S.H., Jin, H.O., Yoo, D.H., Lee, S.J., An, S., Choe, T.B., Park, M.J., Hong, S.I., Park, I.C. & Rhee, C.H. (2007) Sulindac-derived reactive oxygen species induce apoptosis of human multiple myeloma cells via p38 mitogen activated protein kinase-induced mitochondrial dysfunction. Apoptosis, 12, 195209.
  • Wada, T. & Penninger, J.M. (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene, 23, 28382849.
  • Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J. & Greenberg, M.E. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270, 13261331.